Revenue
0 USD
2026 Q3 · USD
Exact inputs and evidence
- Revenue: 0 USD Source
Fundies. English
ACRO BIOMEDICAL CO., LTD.
EDGARAnnual consolidated revenue for 2026: about USD 0, using the latest reported figures. The previous period, 2025, was about USD 0.
Latest quarter
- Cash and cash equivalents
- 215 thousand USD Source
Exact value
215494 USD
- Long-term debt including current maturities
- Not available
- Shares outstanding
- 60 million shares Source
Exact value
60042000 shares
Reported share-count change
0.00% · 0 shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
Trailing twelve months
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
Revenue
0 USD
2025-07-01 – 2026-06-30
Net income
-140 thousand USD
2025-07-01 – 2026-06-30
Exact inputs and evidence
Operating cash flow
-140 thousand USD
2025-07-01 – 2026-06-30
Exact inputs and evidence
- Operating cash flow: -170925 USD · 2025-01-01 – 2025-09-30 Source
- Operating cash flow: -116515 USD · 2025-01-01 – 2025-06-30 Source
- Operating cash flow: -196302 USD · 2025-01-01 – 2025-12-31 Source
- Operating cash flow: -170925 USD · 2025-01-01 – 2025-09-30 Source
- Operating cash flow: -49821 USD · 2026-01-01 – 2026-03-31 Source
- Operating cash flow: -60325 USD · 2026-01-01 – 2026-06-30 Source
- Operating cash flow: -49821 USD · 2026-01-01 – 2026-03-31 Source
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-08-14.
Financial data available through: 2025-12-31.
Coverage by financial measure
- Revenue: 6 of 11 periods available· newest 2025-12-31
- Operating income: 11 of 11 periods available· newest 2025-12-31
- Net income: 11 of 11 periods available· newest 2025-12-31
- Operating cash flow: 11 of 11 periods available· newest 2025-12-31
- capital expenditure: No compatible figures in this window
- Total assets: 6 of 11 periods available· newest 2025-12-31
- Total liabilities: 5 of 11 periods available· newest 2024-12-31
- Current assets: 6 of 11 periods available· newest 2025-12-31
- Current liabilities: 6 of 11 periods available· newest 2025-12-31
- Cash and cash equivalents: 1 of 11 periods available· newest 2017-09-30
- long term debt: No compatible figures in this window
- Shares outstanding: 6 of 11 periods available· newest 2025-12-31
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Revenue
USD 0Prior period
USD 0
–
Current period
USD 0
–
Exact inputs and evidence
0 − 0 = 0 USD
0 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source0 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 58,849Prior period
−USD 42,297
–
Current period
−USD 101,146
–
Exact inputs and evidence
-101146 − -42297 = -58849 USD
-42297 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-101146 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 159,610Prior period
−USD 36,692
–
Current period
−USD 196,302
–
Exact inputs and evidence
-196302 − -36692 = -159610 USD
-36692 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-196302 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Capital expenditure.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
2026 2025-01-01 – 2025-12-31
- Revenue USD 0
- Operating costs Derived USD 154,024
- Operating income −USD 154,024
- Tax, interest and other Derived −USD 52,878
- Net income −USD 101,146
Cash
- Operating cash flow −USD 196,302
- Capital expenditure Unavailable An input is unavailable.
- Free cash flow Derived Unavailable An input is unavailable.
Share of revenue by period
- Net income
- Tax, interest and other
- Operating costs
- 2017 Operating loss: operating costs were 100% of revenue.
- 2022 Operating loss: operating costs were 742% of revenue.
- 2023 Operating loss: operating costs were 2,510% of revenue.
- 2024 Not shown: operating income or net income is not reported.
- 2025 Not shown: operating income or net income is not reported.
- 2026 Not shown: operating income or net income is not reported.
Values and sources
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2017 2016-10-01 – 2017-09-30 | 510000 | 512248 Derived | -2248 | 0 Derived | -2248 | Unavailable | Source
|
| 2022 2021-01-01 – 2021-12-31 | 1197500 | 8891078 Derived | -7693578 | 4250 Derived | -7697828 | Unavailable | Source
|
| 2023 2022-01-01 – 2022-12-31 | 658500 | 16528237 Derived | -15869737 | 1706 Derived | -15871443 | Unavailable | Source
|
| 2024 2023-01-01 – 2023-12-31 | 0 | 8804367 Derived | -8804367 | 3206 Derived | -8807573 | Unavailable | Source
|
| 2025 2024-01-01 – 2024-12-31 | 0 | 37958 Derived | -37958 | 4339 Derived | -42297 | Unavailable | Source
|
| 2026 2025-01-01 – 2025-12-31 | 0 | 154024 Derived | -154024 | -52878 Derived | -101146 | Unavailable | Source
|
Amounts are exact, in USD.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
USD 0 2026
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2017 | Revenue | 510000 |
|
| 2022 | Revenue | 1197500 |
|
| 2023 | Revenue | 658500 |
|
| 2024 | Revenue | 0 |
|
| 2025 | Revenue | 0 |
|
| 2026 | Revenue | 0 |
|
Revenue growth
Change in revenue from the same financial period one year earlier.
-100% 2024
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2017 | Year over year | No prior comparable period |
|
| 2022 | Year over year | No prior comparable period |
|
| 2023 | Year over year | -45% |
|
| 2024 | Year over year | -100% |
|
| 2025 | Year over year | No prior comparable period |
|
| 2026 | Year over year | No prior comparable period |
|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
Operating margin -2,410% 2023
Net margin -2,410.2% 2023
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2017 | Operating margin | -0.4% |
|
| 2022 | Operating margin | -642.5% |
|
| 2023 | Operating margin | -2,410% |
|
| 2024 | Operating margin | Not reported |
|
| 2025 | Operating margin | Not reported |
|
| 2026 | Operating margin | Not reported |
|
| 2017 | Net margin | -0.4% |
|
| 2022 | Net margin | -642.8% |
|
| 2023 | Net margin | -2,410.2% |
|
| 2024 | Net margin | Not reported |
|
| 2025 | Net margin | Not reported |
|
| 2026 | Net margin | Not reported |
|
| 2017 | Free cash flow margin | Not reported |
|
| 2022 | Free cash flow margin | Not reported |
|
| 2023 | Free cash flow margin | Not reported |
|
| 2024 | Free cash flow margin | Not reported |
|
| 2025 | Free cash flow margin | Not reported |
|
| 2026 | Free cash flow margin | Not reported |
|
Operating cash flow
Cash generated by the company’s normal business operations.
USD -196.3K 2026
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2017 | Operating cash flow | -463344 |
|
| 2022 | Operating cash flow | 299335 |
|
| 2023 | Operating cash flow | -147481 |
|
| 2024 | Operating cash flow | -15446 |
|
| 2025 | Operating cash flow | -36692 |
|
| 2026 | Operating cash flow | -196302 |
|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2017 | Free cash flow | Unavailable |
|
| 2022 | Free cash flow | Unavailable |
|
| 2023 | Free cash flow | Unavailable |
|
| 2024 | Free cash flow | Unavailable |
|
| 2025 | Free cash flow | Unavailable |
|
| 2026 | Free cash flow | Unavailable |
|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
1,022.5% 2025
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2017 | Liabilities / assets | 6.7% |
|
| 2022 | Liabilities / assets | 15.4% |
|
| 2023 | Liabilities / assets | 29.3% |
|
| 2024 | Liabilities / assets | 539.6% |
|
| 2025 | Liabilities / assets | 1,022.5% |
|
| 2025-12-31 | Liabilities / assets | Not reported |
|
Current assets to current liabilities
Current assets divided by current liabilities.
0.04× 2026
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2017 | Current assets / current liabilities | 14.83× |
|
| 2022 | Current assets / current liabilities | 7.71× |
|
| 2023 | Current assets / current liabilities | 3.27× |
|
| 2024 | Current assets / current liabilities | 0.01× |
|
| 2025 | Current assets / current liabilities | 0.02× |
|
| 2026 | Current assets / current liabilities | 0.04× |
|
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2017 2016-10-01 – 2017-09-30 | −USD 2,248 Exact valueExact value: -2248 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 463,344 Exact valueExact value: -463344 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2018 2017-10-01 – 2018-09-30 | USD 419,660 Exact valueExact value: 419660 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 140,419 Exact valueExact value: -140419 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2019 2018-10-01 – 2019-09-30 | −USD 370,747 Exact valueExact value: -370747 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 79,692 Exact valueExact value: 79692 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2020 2019-01-01 – 2019-12-31 | −USD 371,604 Exact valueExact value: -371604 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 59,709 Exact valueExact value: -59709 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2021 2020-01-01 – 2020-12-31 | −USD 117,453 Exact valueExact value: -117453 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 199,460 Exact valueExact value: -199460 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2022 2021-01-01 – 2021-12-31 | −USD 7.7 million Exact valueExact value: -7697828 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 299,335 Exact valueExact value: 299335 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2023 2022-01-01 – 2022-12-31 | −USD 15.87 million Exact valueExact value: -15871443 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 147,481 Exact valueExact value: -147481 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2024 2023-01-01 – 2023-12-31 | −USD 8.81 million Exact valueExact value: -8807573 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 15,446 Exact valueExact value: -15446 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2025 2024-01-01 – 2024-12-31 | −USD 42,297 Exact valueExact value: -42297 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 36,692 Exact valueExact value: -36692 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2026 2025-01-01 – 2025-12-31 | −USD 101,146 Exact valueExact value: -101146 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 196,302 Exact valueExact value: -196302 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
45 filings · 1,927 latest values · 1,927 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001622996, 1622996, ACBM, acbm, edgar:1622996, kwh, kwvh
Also known as ACRO BIOMEDICAL CO., LTD., KILLER WAVES HAWAII, INC